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Abstract: 
In this issue of Neuron, Lin and colleagues (2015) report an optical method to precisely 
manipulate the activity of GABAA receptors by designing a mutant receptor that binds 
photosensitive compounds. This allows for studying GABAA receptors in situ and 
represents a valuable tool to investigate how inhibition affects brain physiology. 
Ensuring that cell excitability in the brain is controlled, and can form part of a meaningful neural 
code, is mostly the responsibility of the neurotransmitter GABA and its associated receptors. 
GABA is essentially the conductor of an inhibitory orchestra formed from interneurons and 
GABA receptors, which together, cause inhibition either by rapidly activating anion flux across 
the cell membrane (via GABAA receptors) or by initiating slower second messenger mediated 
signalling (via GABAB receptors). To investigate how inhibition affects brain physiology and how 
its dysfunction can precipitate numerous diseases requires clear mechanistic understanding. 
The major investigative tool usually employed for this purpose is electrophysiology, but in this 
issue of Neuron, Lin and colleagues (2015) describe a new elegant optical method based on a 
range of light-sensitive compounds. When bound to GABAA receptors, these molecules can 
enable the precise temporal and spatial ‘tuning’ of GABAA receptor activity following their 
exposure to light of specified wavelengths. They are set to become a valuable addition to the 
panoply of optical methods that are revolutionising our understanding of the nervous system. 
Manipulating the activity of native GABAA receptors using photochemical approaches is quite 
challenging, because GABAA receptors can show some inherent sensitivity to UV light (Chang 
et al., 2001), and because ligand specificity is critically important if particular isoforms of the 
GABAA receptor are the intended targets. The authors sought to confer selectivity by 
exchanging a residue near the GABA binding site for cysteine (Cys). They then constructed a 
modular-based compound, termed a photoswitchable-tethered-ligand (PTL; Figure 1) that could 
anchor itself to the Cys residue, and by using light to change the molecule’s conformation, 
facilitate entry of a ligand into the GABA binding site (located at the β-α subunit interface) to 
manipulate receptor activity. The PTL has three modules: a maleimide, which covalently binds 
to Cys and creates a highly stable S-C bond on the GABAA receptor; this is linked to an 
azobenzene group, which can flip between cis and trans states when exposed to specific 
wavelengths of light (the ‘photoswitch’); finally, this is attached to the third module, a GABAA 
receptor ligand, which in this study is usually a guanidinium derivative of GABA that binds to the 
orthosteric (neurotransmitter binding) site of the receptor. Finally, a repeat methylene spacer ((-
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CH2-)n, where n = 1-4) was also included in some compounds between the azobenzene and 
receptor ligand groups, presumably to increase molecular flexibility for ligand binding. 
The principle underlying the use of PTLs is that light-induced conformational flipping of the 
molecule between cis and trans will change its ability to access and bind to the GABA binding 
site. Interestingly, although the PTL binding modules were all designed to be agonists, they 
unexpectedly showed antagonist behaviour, which was also apparent in the authors’ previous 
study using muscimol (Lin et al., 2014); nevertheless, they are still very useful tools for 
manipulating GABA receptor activity.  
It is often reasonably assumed that ligands that target the orthosteric site should also compete 
with GABA for binding. Using recombinant GABAA receptors, Lin et al., selected Threonine 125 
in the binding domain for replacement by Cys (α1T125Cβ2γ2) and showed a competitive-type 
displacement of the GABA dose response curve in the presence of a trans-PTL, suggesting that 
the PTL is sufficiently flexible (particularly if there is a spacer) for the guanidinium-ligand to bind 
and dissociate from the orthosteric site despite the PTL being tethered by the maleimide group. 
The degree of inhibition is quite extensive, reaching approximately 80% for the most effective 
PTL inhibiting half-maximal GABA responses, though at GABA concentrations likely to exist at 
inhibitory synapses (1-3 mM), competitive inhibition may be reduced (to ~30%).  
To explore the usefulness of these tool compounds for manipulating the activity of other 
members of the GABAA receptor family, the Cys substitution method was used for α2 - α6 
subunits for sequential expression with β2 and γ2 subunits. The authors relocated the Cys 
substitution from that used for α1 subunits, to a position that was now within a 4-amino acid 
motif considered to be important for determining the different potencies of GABA at GABAA 
receptors containing different α subunits (Bohme et al., 2004). Reassuringly, the Cys 
substitutions maintained functional neutrality. Thus, Lin et al., had succeeded in creating a 
highly useful palette of Cys-substituted GABAA receptor isoforms that could be differentially 
regulated by light. 
Such a palette enables a number of interesting experiments to be conducted. We know that 
GABAA receptor isoforms show differential distribution throughout the brain, even within the 
membrane domains of a single neuron (soma, dendrites, axon initial segment; Fritschy and 
Brunig, 2003). Now we have a means to dissect their relative subcellular distribution and 
explore their relative physiological function. The authors addressed this aspect by expressing 
two GABAA receptor subunits in hippocampal neurons using α1T125C and α5E125C. This enabled 
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PTLs to manipulate receptors activated by prior 2-photon uncaging of (trimethylphosphine-
caged) GABA. The relative sensitivities of the PTL-tethered receptors to the uncaged GABA 
suggested clustering of α1 subunits in ‘hot spots’, with α5 receptors more evenly distributed, in 
accord with their presumed synaptic (α1) and extra/perisynaptic (α5) locations (Brunig et al., 
2002; Serwanski et al., 2006).  
Lin et al., extended their study of light-regulated GABAA receptors to neurons using viral 
transduction to express Cys mutant α subunits. In hippocampal slices expressing α1T125C, light-
exposed tethered PTLs reduced the amplitudes of evoked inhibitory postsynaptic currents 
(eIPSCs) by > 50%. A complete block of synaptic inhibition is unlikely to be achieved as 
different isoforms of GABAA receptors other than those containing α1 subunits will likely 
underpin synaptic inhibition, and the Cys-maleimide reaction is unlikely to be 100% complete. 
This can make the exact contributions of specific α subunits to physiological processes more 
difficult to assess. Nevertheless, by exchanging the type of α subunit expressed in neurons, 
e.g., extrasynaptic α5E125C, the diversity of this method was demonstrated by using light to 
manipulate GABAA receptor activity associated with tonic inhibition. 
Of course, if synaptic (and tonic) inhibition is to be controlled by light then it is important to have 
reagents that not only respond to light with fast on-off kinetics, enabling a high degree of 
temporal resolution, but also be able to deliver both PTLs and sufficient light density to deep 
lying neurons contained in slices or present in vivo.  The kinetics of conformational flipping for 
the PTLs will be quite fast (100 – 200 ms) when exposed to light and can, by blocking GABAA 
receptors, cause temporally precise effects on single action potentials. The thermal ‘resting’ 
stability expected of the azobenzene is evident since when either the cis or trans forms are not 
exposed to light, they are stable over 10 - 30 mins, which is extremely valuable for experimental 
protocols.  
For spatial penetration, particularly for affecting GABAA receptors in deep lying neurons, the 
authors infused the PTL into the intact brain by a delivery pipette before preparing slices. It was 
notable that the extent of photoswitching affecting GABAA receptors declined when moving from 
the pial surface of the slice to deeper lying cells. This is to be expected, but even so, the method 
has impressive penetration with light reaching approximately 350 µm into the slice, and 
presumably this can be further accentuated by using optic fibres to limit light scattering by the 
neuronal parenchyma. 
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Having extended the repertoire of the PTL approach to tuning synaptic and tonic inhibition, and 
demonstrated good temporal and spatial dynamics to photoswitching, the authors tested their 
methodology in vivo by expressing Cys mutant α subunits in intact brain using viral transduction, 
and by creating a knock-in mouse line expressing α1T125C subunits. 
By using viruses, mutant GABAA receptors can be expressed deep into neural tissue, and 
located to identifiable fluorophore-expressing neurons (e.g., genetically-engineered parvalbumin 
(PV) interneurons (INs) expressing tdtomato). PTLs can also be infused deep into the brain, and 
by using 2-photon targeted patch clamp recording, the spiking profile of PV INs could be 
switched from bursting- to continuous-type firing, when inhibition of Cys-substituted GABAA 
receptors was induced with a photoswitched PTL or relieved, respectively. This established the 
viability of the method in vivo, but to control for any aberrant over-expression of Cys mutant 
receptors following viral transduction, the authors created a global knock-in mouse which 
replaced native α1 subunits with α1T125C. 
This photoswitch-ready mutant mouse line only requires the delivery of PTLs to be able to gate 
GABAA receptors using light. Four cell types exhibiting differential expression patterns for α1 
subunits were chosen for the study. As expected, for those cell types where α1 subunit GABAA 
receptors are dominant or even the only receptor isoform expressed, photoswitching induced a 
strong inhibitory effect on IPSCs; whilst IPSC photoswitching was less effective for cells 
expressing α1 with other GABAA receptor isoforms, and completely ineffective for cell types that 
lacked α1 subunit expression.  
Using awake α1T125C-knock-in mice, the authors show photoswitch-control of visually-evoked 
spike firing rates as well as γ-oscillations, which effectively demonstrated the possibility of 
interrogating physiological functions of specific GABAA receptor isoforms in the nervous system. 
If cell-type specific knock-ins are created, this interrogation can proceed at the single cell level 
as well as at the level of specific neural networks, establishing the behaviour and role of IN 
subpopulations (Klausberger et al., 2003).  
In designing a mutant receptor that binds photosensitive compounds, the authors have created 
a very powerful set of tools for studying GABAA receptors in situ. These tools need validation 
against a set of controls and Lin et al., have been very thorough in this regard, testing the PTLs 
against other membrane proteins. However, any free surface-exposed Cys residue will in 
principle bind the maleimide group of the PTL. For GABAA receptor subunit, there are relatively 
few ‘free’ Cys residues in the extracellular domain (ECD). Two Cys residues are engaged in a 
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Cys-Cys bond, forming the Cys loop that characterises many of the receptors in the pentameric 
ligand-gated ion channel family; so they are presumably unavailable to bind maleimide. Another 
potential neurotransmitter receptor that is worth screening is the inhibitory glycine receptor. It 
does have 5 Cys residues in the ECD, four of which may form two Cys-Cys bonds, leaving one 
possibly free for interaction with maleimide.  
An interesting aspect of this study is that the PTLs exhibit antagonist properties, which is very 
useful for inhibiting GABAA receptor activity; however, it would also be valuable to be able to 
activate or positively modulate GABAA receptor function as reported for native GABAA receptors 
using an azobenzene-based propofol derivative (Yue et al., 2012). Possibly this is easier to 
achieve from an allosteric site rather than the orthosteric site, since Lin et al., note the removal 
of the negatively-charged carboxyl on the guanidinium moiety seems to prevent agonist activity. 
The direction of travel adopted by Lin and colleagues’ study opens many new investigative 
possibilities for probing the role of GABAA receptors in neural circuit behaviour. The need to 
express mutant GABAA receptors in neurons seems a small ‘price to pay’ for the experimental 
diversity that becomes available from using PTLs, though ultimately trying to emulate these 
experiments with native GABAA receptors and other modular-based compounds remains a 
challenge (Mortensen et al., 2014).  
 
 
Figure 1. Photo-inhibition of α1T125Cβ2γ2 GABAA receptor by a tethered PTL  
(A) PTLs are composed of 3 linked modules: A cysteine reactive maleimide; a photoswitchable 
azobenzene; and a GABA (guanidinium derivative) ligand.  
(B) Homology model of α1β2γ2 showing the interfacial GABA binding site with binding loops A 
(red), B (blue) and C (orange) from the principal (+) β2 subunit and loops D (cyan), E (purple) 
and F (green) from the complementary (-) α1 subunit. Both α1T125C and the PTL are shown in 
yellow. (Ba) In this example, the cis form of the PTL does not enter the GABA binding site, 
however, when photoswitched by 500 nm light into the trans isomer (Bb), the ligand-group 
accesses the binding site displacing GABA and causing inhibition. Light at 380 nm reverts the 
PTL back to its cis form relieving inhibition.  
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